Bloodlines market is driven by increasing prevalence of renal disorders and rising number of dialysis patients across the globe. Bloodlines are needed to be replaced every time, when the dialysis is performed and they are disposable medical supplies. In addition, rising number of dialysis procedures thus creates huge demand for bloodlines across the globe. Nevertheless, Technological advancements such as airless blood tubing sets are creating numerous opportunities for the growth of the global market across the globe.Bloodlines Market was valued at US$ 825.9 million in 2024 and is projected to grow at a CAGR of 7.0% to reach US$ 1529.9 million by 2034.

The report "Bloodlines Market, By Type (PVC, PECG, and Others), By End-User (Hospitals & Ambulatory Surgical Centers, Specialty Clinics, and Hemodialysis Centers), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) -Trends, Analysis and Forecast till 2034"

Key Highlights:

• On June 2019, Terumo Corporation which is a leading global medical device manufacturer has announced its strategic partnership with Orchestra BioMed, Inc. BioMed, Inc. is a biomedical innovation company providing high-impact solutions for large unmet needs in procedure-based medicine.
• On August 2019, B. Braun Medical Inc. announced the integration of their Infusomat® Space™ large volume pumps with Epic’s electronic health record (EHR) platform at Prime Healthcare – Huntington Beach Hospital.

Key Market Insights from the report:          

Bloodlines Market was valued at US$ 825.9 million in 2024 and is projected to grow at a CAGR of 7.0% to reach US$ 1529.9 million by 2034. The market report has been divided on the basis of type, end-user, and region.

• By type, the global bloodlines market is segmented into PVC, PECG, and others.
• By end-use, the global bloodlines market is categorized into hospitals and ambulatory surgical centers, specialty clinics, and hemodialysis centers. Hospitals and ambulatory surgical centers segment is expected to dominate the global market over the forecast period, owing to the growing incidence of cardiovascular disorders and rising aging population.
• By region, North America is accounted to be the most dominating for the global market over the forecast period, owing to growing number hemodialysis patients. Europe accounts for the second largest market for bloodlines due to presence of numerous key players.

Browse 60 market data tables* and 35 figures* through 140 slides and in-depth TOC on "Bloodlines Market, By Type (PVC, PECG, and Others), By End-User (Hospitals & Ambulatory Surgical Centers, Specialty Clinics, and Hemodialysis Centers), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) -Trends, Analysis and Forecast till 2034"

The prominent player operating in the global bloodlines market includes B.Braun Melsungen AG, Baxter Healthcare Corp., NiproMedical Corporation, Fresenius SE & Co KGaA, Gambro AB, Fenwal, Inc., EdwardsLifesciences LLC, Haemotronic SpA, Terumo Corp., and Medica S.r.l

To know more

Contact Us:

Sales

Prophecy Market Insights

U.S: 1 860 531 2574

RoW: 91 7775049802

Email- [email protected]

Website- www.prophecymarketinsights.com

Blog- www.prophecyjournals.com